No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Kronos Bio, Genentech to Terminate Research Partnership; Shares Down Pre-Bell
Express News | Kronos Bio Inc - Enters Transition Agreement With Genentech
Kronos Bio Announces Leadership Change With Deborah Knobelman Appointed as President and Interim CEO
Kronos Bio: Bischofberger Will Remain on Board and Continue to Be Available as Adviser >KRON
Press Release: Kronos Bio Announces CEO Transition and Reduction in Force
Kronos Bio Restructures Workforce and Leadership